Literature DB >> 8035313

Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.

A Berson1, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps, D Pessayre.   

Abstract

The effects of nilutamide on the mitochondrial respiratory chain were investigated in rats. In isolated mitochondria, nilutamide (100 microM) inhibited respiration that was supported by substrates feeding electrons into complex I of the respiratory chain but did not inhibit respiration that was supported by substrates donating electrons to complexes II, III or IV. Inhibition of complex I occurred without any lag time. In submitochondrial particles, nilutamide (100 microM) decreased both oxygen consumption mediated by NADH and the oxidation of NADH; addition of superoxide dismutase and catalase did not alleviate inhibition. There was no electron spin resonance evidence for detectable mitochondrial formation of the nilutamide nitro anion free radical by submitochondrial particles or for the formation of iron-nitrosyl complexes with mitochondrial Fe-S clusters in isolated hepatocytes. Severe inhibition of complex I by nilutamide (500 microM) led to upstream inhibition of fatty acid beta-oxidation. Nilutamide (100 microM) decreased the mitochondrial membrane potential and ATP formation in mitochondria energized by malate plus glutamate. In hepatocytes incubated without glucose, nilutamide (500 microM) led to an early (2 hr) drop in cellular ATP and early (4 hr) toxicity. With 5 mM glucose, however, ATP was not decreased and toxicity was mild at these early times. It was concluded that nilutamide itself inhibited the mitochondrial respiratory chain at the level of complex I and decreased ATP in hepatocytes incubated without glucose, which resulted in early toxicity. In the presence of glucose, ATP was not depleted at early times and delayed toxicity was probably the result of an oxidative stress (as previously reported).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035313

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Fulminant hepatic failure due to nilutamide hepatotoxicity.

Authors:  Shehzad N Merwat; Wareef Kabbani; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2008-08-08       Impact factor: 3.199

2.  Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform.

Authors:  Sashi Nadanaciva; Payal Rana; Gyda C Beeson; Denise Chen; David A Ferrick; Craig C Beeson; Yvonne Will
Journal:  J Bioenerg Biomembr       Date:  2012-06-12       Impact factor: 2.945

Review 3.  Managing the challenge of chemically reactive metabolites in drug development.

Authors:  B Kevin Park; Alan Boobis; Stephen Clarke; Chris E P Goldring; David Jones; J Gerry Kenna; Craig Lambert; Hugh G Laverty; Dean J Naisbitt; Sidney Nelson; Deborah A Nicoll-Griffith; R Scott Obach; Philip Routledge; Dennis A Smith; Donald J Tweedie; Nico Vermeulen; Dominic P Williams; Ian D Wilson; Thomas A Baillie
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

4.  Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening.

Authors:  Kevin J Coe; Yankai Jia; Han Kiat Ho; Peter Rademacher; Theo K Bammler; Richard P Beyer; Frederico M Farin; Libby Woodke; Stephen R Plymate; Nelson Fausto; Sidney D Nelson
Journal:  Chem Res Toxicol       Date:  2007-08-17       Impact factor: 3.739

Review 5.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

6.  Evaluating biological activity of compounds by transcription factor activity profiling.

Authors:  Alexander Medvedev; Matt Moeser; Liubov Medvedeva; Elena Martsen; Alexander Granick; Lydia Raines; Ming Zeng; Sergei Makarov; Keith A Houck; Sergei S Makarov
Journal:  Sci Adv       Date:  2018-09-26       Impact factor: 14.136

Review 7.  The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity.

Authors:  Volker M Lauschke; Magnus Ingelman-Sundberg
Journal:  Int J Mol Sci       Date:  2016-10-12       Impact factor: 5.923

8.  MitoToxy assay: A novel cell-based method for the assessment of metabolic toxicity in a multiwell plate format using a lactate FRET nanosensor, Laconic.

Authors:  Yasna Contreras-Baeza; Sebastián Ceballo; Robinson Arce-Molina; Pamela Y Sandoval; Karin Alegría; Luis Felipe Barros; Alejandro San Martín
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

Review 9.  Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods.

Authors:  Milos Mihajlovic; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.